ESC 365 - Circulating levels of amyloid-beta (1-40) peptide associate with cardiometabolic traits and risk for metabolic dysfunction-associated steatotic liver disease

FCVB 2024 Premium Access

Circulating levels of amyloid-beta (1-40) peptide associate with cardiometabolic traits and risk for metabolic dysfunction-associated steatotic liver disease

Session: Targets and markers of cardiometabolic disease

Topic: Biomarkers

Speaker: Doctor K. Sopova (Mannheim, DE)

Event: Frontiers in CardioVascular Biomedicine 2024

Congress Presentation

About the speaker

Doctor Kateryna Sopova

University Medical Centre of Mannheim, Mannheim (Germany)

0 follower

1 more presentation in this session

Identifying potential drug targets for non-alcoholic fatty liver disease: a drug target Mendelian randomization study

Speaker: Miss N. Hukerikar (London, GB)

Access the full session

Targets and markers of cardiometabolic disease

Speakers: Doctor K. Sopova, Miss N. Hukerikar

About the event

Frontiers in CardioVascular Biomedicine 2024

12 April - 14 April 2024

Sessions Presentations

Congress

ESC 365 is supported by